Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Large Drop in Short Interest

Fresenius SE & Co. (OTCMKTS:FSNUY) was the target of a significant decrease in short interest in July. As of July 31st, there was short interest totaling 114,842 shares, a decrease of 40.6% from the July 15th total of 193,488 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 624,752 shares, the days-to-cover ratio is currently 0.2 days.

Analyst Ratings Changes

Several equities research analysts have issued reports on FSNUY shares. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Fresenius SE & Co. in a report on Thursday, August 6th. Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a research report on Tuesday, July 21st. Three analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company has an average rating of “Buy”.

Fresenius SE & Co. Price Performance

Fresenius SE & Co. stock traded down $0.08 during mid-day trading on Tuesday, hitting $13.58. 124,187 shares of the company were exchanged, compared to its average volume of 158,777. Fresenius SE & Co. has a 1-year low of $10.33 and a 1-year high of $33.93. The company has a quick ratio of 0.98, a current ratio of 1.27 and a debt-to-equity ratio of 0.41. The business has a fifty day moving average of $12.22 and a 200 day moving average of $12.73. The company has a market capitalization of $30.60 billion, a PE ratio of 17.19 and a beta of 0.61.

Fresenius SE & Co. (OTCMKTS:FSNUY) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). Fresenius SE & Co. had a net margin of 6.67% and a return on equity of 10.33%. The firm had revenue of $6.91 billion for the quarter, compared to the consensus estimate of $6.65 billion. As a group, sell-side analysts expect that Fresenius SE & Co. will post 1.08 earnings per share for the current year.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.